Physician

Andrew C Westfall, MD

According to 2025 Medicare claims, Andrew Westfall, MD (NPI: 1003989781) practices ophthalmology in the Salem, OR market, with the plurality of this provider's patient population coming from Marion, OR. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LLP (NPI: 1528181674; TIN: 93-1152985) and primary practice location at 97302-2152.

Westfall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 548 traditional Medicare patients, billed 20,410 HCPCS/CPT codes, and received $1,424,330 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 206 prescription claims across 96 beneficiaries totaling $11,945 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $82. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $879,192 to $1,424,330. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $6,714 to $11,945. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$817K$1.6M2015 Medicare payment: $879,192 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $909,884 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,025,650 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,305,728 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,633,626 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,491,032 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,433,776 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,337,384 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,266,787 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,424,330 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156075,877$879,192
20165965,159$909,884
20175615,514$1,025,650
20185625,981$1,305,728
20195406,241$1,633,626
20205095,894$1,491,032
20215635,887$1,433,776
20225066,210$1,337,384
202351514,738$1,266,787
202454820,410$1,424,330

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.4K$19K2015 Drug cost: $6,714 (USD; Tot_Drug_Cst)2016 Drug cost: $8,054 (USD; Tot_Drug_Cst)2017 Drug cost: $9,843 (USD; Tot_Drug_Cst)2018 Drug cost: $7,799 (USD; Tot_Drug_Cst)2019 Drug cost: $12,559 (USD; Tot_Drug_Cst)2020 Drug cost: $8,809 (USD; Tot_Drug_Cst)2021 Drug cost: $18,218 (USD; Tot_Drug_Cst)2022 Drug cost: $18,884 (USD; Tot_Drug_Cst)2023 Drug cost: $15,401 (USD; Tot_Drug_Cst)2024 Drug cost: $11,945 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201591179$6,714
201671150$8,054
201769187$9,843
201881190$7,799
201998265$12,559
202079206$8,809
2021105291$18,218
2022102257$18,884
2023120259$15,401
202496206$11,945

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye130134$131
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more142142$123
67028Injection of drug into eye2001,069$93
92014Established patient complete exam of visual system355482$89
92134Imaging of retina453945$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate733,324$3,926
Ketorolac TromethamineKetorolac Tromethamine231,023$1,678
Atropine SulfateAtropine Sulfate12585$633
Timolol MaleateTimolol Maleate301,973$245
LatanoprostLatanoprost15918$142

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$82ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew C. Westfall, MD?

Tedicare shows public-source Medicare data for Andrew C. Westfall, MD (NPI 1003989781), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew C. Westfall, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew C. Westfall, MD?

Andrew C. Westfall, MD is linked to RETINA CONSULTANTS, LLP (billing NPI 1528181674) in the available physician profile data.

Does Andrew C. Westfall, MD have Open Payments data?

Andrew C. Westfall, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.